FDA D.I.S.C.O. Burst Edition: FDA approv...

Listen to a soundcast of the March 3, 2023, FDA approval of Verzenio (abemaciclib) with endocrine therapy for patients with HR-positive, HER2-negative, node-positive, early breast cancer. 

Listen to a soundcast of the February 9, 2023, FDA approval of Jemperli (dostarlimab-gxly) for mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed on or following a prior platinum-containing regimen. 

Listen to a soundcast of the February 3, 2023, FDA approval of Trodelvy (sacituzumab govitecan-hziy) for HR-positive breast cancer. 

The FDA authorized the first new versions of the Covid-19 vaccines since they were introduced in late 2020, and the updated formulations target the newest Omicron subvariants. Dr. Abdul El-Sayed, epidemiologist and host of Crooked’s “America Dissected,” tells us what we need to k ... Show More

<p>Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.</p> <p>Read the related article on the <a href= "https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-trea ... Show More

The White House Coronavirus Task Force just finished meeting as cases surge and Omicron takes over. But, this afternoon, a possible game changing pill has been approved by the FDA. As Democratic Senator Joe Manchin faces criticism from his own party, there is a new, very public ... Show More

The Food and Drug Administration has authorized a vaccine by Pfizer and BioNTech that will start reaching the most at-risk Americans today. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks through the final hurdles the vaccine had to clear over the weekend. To learn more ab ... Show More